Table 1 Clinical characteristics and risk factors of 58 patients with bacteremia caused by Aeromonas species

Gender

 Male

40 (70.0)

12 (75.0)

28 (66.7)

0.752

–

–

–

 Female

18 (30.0)

4 (25.0)

14 (33.3)

Age, years (means ± SD)

61.1 ± 16.7

56.56 ± 14.45

62.76 ± 17.30

0.208

–

–

–

Age

  < 65

30 (51.7)

10 (62.5)

20 (47.6)

0.311

–

–

–

 ≥ 65

28 (48.3)

6 (37.5)

22 (52.4)

Symptoms and signs

  Fever (> 39℃)

31

6 (37.5)

25 (59.5)

0.133

–

–

–

  Leukocytosis

26

6 (37.5)

20 (47.6)

0.489

–

–

–

  Thrombocytopenia

34

13 (81.3)

21 (50)

0.031*

  Neutropenia

19

7 (43.8)

12 (28.6)

0.271

–

–

–

Microbial findings

  Monomicrobial

49 (84.5)

16 (100.0)

33 (78.6)

0.051

–

–

–

  Polymicrobial

9 (15.5)

0 (0.0)

9 (21.4)

Antimicrobial susceptibility

 MDR

9 (15.5)

4 (25.0)

5 (11.9)

0.243

–

–

–

 Non MDR

49 (84.5)

12 (75.0)

37 (88.1)

 Source of infection

  Community acquired

34 (58.6)

13 (81.3)

21 (50)

0.031*

3.201

0.57–18.00

0.187

  Nosocomial infection

24 (41.4)

3 (18.8)

21 (50)

Co-morbidity

 Liver cirrhosis

26 (44.8)

11 (68.8)

15 (35.7)

0.024*

7.41

1.32–41.55

0.023*

  Diabetes mellitus

7 (12.1)

2 (12.5)

5 (11.9)

1.000

–

–

–

 Malignancy

18 (31.0)

6 (37.5)

12 (28.6)

0.538

–

–

–

  Leukemia

8 (13.8)

3 (18.8)

5 (1.9)

0.672

–

–

–

Treatment

 inappropriate empirical antimicrobials

15 (25.9)

10 (62.5)

5 (11.9)

0.000*

16.91

3.04–94.22

0.001*

Clinical outcomes

 Septic shock

14

11 (68.8)

3 (7.1)

0.000*

–

–

–

  Admission to ICU

10

9 (90)

1 (2.4)

0.000*

–

–

–

 Length of stay in hospital, days

17 (6–24.75)

2.5 (1–6)

19 (11.25–30)

0.000*

–

–

–